NewsRoom Articles - Page 169 of 221

TuesdayMay 11, 2021 2:26 pm

United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App

Simple design enables consumers to prevent medication errors Offers 12 different functionalities with the newest addition of GoodRX Now offering up to 85% discount on most medications at over 70,000 pharmacies Across the United States. Powered by GoodRX Download the APP now and not only manage your medication but save money every time you walk into your local Pharmacy by having your coupons ready United Medical Equipment Business Solutions Network ("UME") is in the business of helping families with medical resources, supplies and providing a network of reliable solutions. One of these solutions is the Medication Management App, developed to…

TuesdayMay 11, 2021 2:06 pm

Predictive Oncology’s (NASDAQ: POAI) C-Level Leaders Provide Company, Operations Update on New Podcast

Bell2Bell podcast features company CEO, CFO, CTO of Helomics subsidiary POAI is “in probably the best situation we’ve been in since the existence of the company,” reports CFO Company anticipates revenue from its unique PeDAL platform Three Predictive Oncology (NASDAQ: POAI) executives were featured guests on a recent Bell2Bell podcast (https://ibn.fm/DumLs). Newly appointed CEO Mel Engle, CFO Bob Myers and Mark Collins, chief technical officer of the company’s Helomics subsidiary, shared updates regarding POAI’s financial footing, current operations and goals for 2021 during the podcast, which delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Named Predictive…

TuesdayMay 11, 2021 10:58 am

Team of German Researchers Looks into Superspreaders Phenomenon

Researchers from the Otto von Guericke University Magdeburg are currently examining the rise and spread of aerosols using artificially manufactured suspended particles and tissue cultivations. The researchers, who hail from the departments of process engineering, biomedical sciences and physics, aim to discover why the “superspreader” phenomenon exists. The group of scientists will be investigating how virus particles in humans are packed into the infectious air bubbles and which processes allow these particles to stick to the airways of other individuals where they then pop, causing infection. The researchers from the process engineering department will be designing simulation models to help…

MondayMay 10, 2021 2:26 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) on Track to Begin Potentially Pivotal Phase 2 GBM Trial This Quarter for Berubicin

During Phase 1 trials, Berubicin showed 44% of patients experienced a clinical benefit of stable disease or better, one being cancer-free after 14 years, and two patients reporting significant tumor reduction (up to 80%) Additional research to be conducted by sublicensee partner WPD Pharmaceuticals, Inc. in Poland, including the first-ever pediatric trial The glioblastoma multiforme (“GBM”) treatment market is expected to reach $1.4 billion by 2027 CNS Pharma positioning to secure a leading role in treating GBM A potentially pivotal Phase 2 trial is on track to commence during Q2 2021 by CNS Pharmaceuticals (NASDAQ: CNSP). This trial is currently…

MondayMay 10, 2021 12:54 pm

Review Finds That Children Develop Mental Health Challenges Post-Concussion

A recent literature review conducted by researchers from the Murdoch Children’s Research Institute has discovered that mental health should be assessed as part of pediatric concussion management and assessment. The review was reported in the “British Journal of Sports Medicine.” Alice Gornall, a PhD candidate from Monash University and a researcher from MCRI, stated that the relationship between mental health and delayed recovery wasn’t well understood, despite the fact that many mental health and post-concussion symptoms overlap. The researchers reviewed 69 articles published from 1980 to 2020. The articles involved more than 89,000 children who had experienced concussions. The children…

MondayMay 10, 2021 12:48 pm

Brain Scientific Inc. (BRSF) Receives First Purchase Order from Department of Veterans Affairs

First order marks a significant milestone as Veterans Affairs runs the largest integrated healthcare system in the country BRSF hopes the relationship will bring cutting-edge brain diagnostics to a nationwide network of veterans’ health care Brain Scientific (OTCQB: BRSF), a commercial-stage, neurology-focused medical device and software company, has announced the start of working with the U.S. Department of Veterans Affairs – VA Medical Centers, which placed the first purchase order of NeuroCap(TM) for one of its hospitals (https://ibn.fm/p3rw0). This move represents a significant milestone because the U.S. Department of Veterans Affairs runs the country's largest integrated healthcare system. "Our team at Brain Scientific is proud to start what it hopes will be a long-term relationship to serve patient…

MondayMay 10, 2021 12:06 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Looks to New Senior Management with Expertise in Development, Clinical Capabilities

Company committed to building presence in U.S. and Europe to advance mission of improving mental health care New appointments will strengthen Cybin’s development and clinical operations globally, solidify position within the industry New leaders bring broad experience, deep insight to their new roles Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing psychedelic therapeutics, recently made key senior-management changes designed to provide the company with added insight and expertise in the expansion of its development and clinical operations in the United States and Europe (https://ibn.fm/FsF0L). The appointments, which are effective immediately, call for Alexander Belser, PhD, to…

FridayMay 07, 2021 2:20 pm

Brain Scientific Inc. (BRSF) Featured in Science and Technology Publication as Company Shaping the Future of Neurology Research

Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the future Article details e-tattoo, BRSF’s solution that can capture big data in real-time about brain activity with possible applications in epileptic seizure predictions E-tattoo could prove invaluable to medical researchers studying neurological conditions or even developers building brain-computer interfaces for mind-controlled electronics, video games Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has been featured in Neoscope as a company that champions cutting-edge research pushing the boundaries of what is possible in…

FridayMay 07, 2021 1:46 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Investigates Alleviating Neurological Disorders with Psychedelics

Tryp Therapeutics is a pharmaceutical developer working to produce novel bioscience solutions, including a synthetic psychedelic drug candidate for treating some chronic pain and eating disorders Tryp CEO Greg McKee appeared on the Entrepreneur Magazine podcast “Action and Ambition” earlier this month to discuss lessons learned on his road to success and to highlight the company’s purpose in developing treatments for helping people be more whole Psychedelic drug therapies have been developing a growing fanbase, highlighted by California state Sen. Scott Wiener’s legislation this year seeking to decriminalize hallucinogenics McKee noted that many military personnel are using psychedelics in an…

FridayMay 07, 2021 12:15 pm

Researchers Propose That Existing Drugs May Help Treat COVID-19

It can take anywhere between a few years to several decades for researchers to develop drugs for various illnesses. However, time is not a luxury that has been afforded to researchers working on therapies to treat patients suffering from the coronavirus. This is why researchers from Northeastern University, in collaboration with Harvard University researchers, devised another way to find treatments for this fatal disease by analyzing treatments already in existence. The group of researchers have published their findings in the “Proceedings of the National Academy of Sciences.” The researchers analyzed all treatments currently available to patients for the treatment of…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

United Medical Equipment Business Solutions Network Inc. Provides Patient Care and Education in One Convenient App

Predictive Oncology’s (NASDAQ: POAI) C-Level Leaders Provide Company, Operations Update on New Podcast

Team of German Researchers Looks into Superspreaders Phenomenon

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) on Track to Begin Potentially Pivotal Phase 2 GBM Trial This Quarter for Berubicin

Review Finds That Children Develop Mental Health Challenges Post-Concussion

Brain Scientific Inc. (BRSF) Receives First Purchase Order from Department of Veterans Affairs

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Looks to New Senior Management with Expertise in Development, Clinical Capabilities

Brain Scientific Inc. (BRSF) Featured in Science and Technology Publication as Company Shaping the Future of Neurology Research

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Investigates Alleviating Neurological Disorders with Psychedelics

Researchers Propose That Existing Drugs May Help Treat COVID-19

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search